PDGFRA and gastrointestinal stromal tumor: These results confirm previous reports on the most frequently missed KIT mutations in GISTs and support the need to refer patients with putative KIT/PDGFRA WT GIST to highly specialized molecular diagnostic centers that implement appropriate NGS panels and bioinformatic pipelines to detect even complex variants19.